申请人:UNIV ANTWERPEN
公开号:WO2013107820A1
公开(公告)日:2013-07-25
The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.
本发明涉及对FAP(成纤维细胞活化蛋白)具有高选择性和特异性的新型抑制剂。所述抑制剂可用作人类和/或兽药,特别是用于治疗和/或预防FAP相关疾病,如但不限于增殖性疾病。